Skip to content

Drug therapy safety in an interprofessional, geriatric, inpatient complex treatment

Drug therapy safety in an interprofessional, geriatric, inpatient complex treatment - TIG

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00022574
Enrollment
325
Registered
2020-11-30
Start date
2020-12-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric Syndromes, Geriatric Resources

Interventions

Group 1: Patient data are collected during the inpatient stay and during follow-up using the questionnaire attached to the ethics application.

Sponsors

Uniklinik Köln - Zentrum Innere Medizin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patient of ward 17.1 of the University Hospital Cologne - Age = 65 years - Multimorbidity (= 2 chronic diseases requiring treatment) - Patient or proxy able to give consent - Sufficient knowledge of German - Degree of care <4

Exclusion criteria

Exclusion criteria: - Age < 65 years - Lack of multimorbidity (< 2 chronic diseases requiring treatment) - Patient or proxy not able to give consent - Lack of German language skills - Degree of care =4

Design outcomes

Primary

MeasureTime frame
The primary endpoint is drug-related rehospitalization. Whether the rehospitalization is drug-related or not is decided by an expert panel of three pharmacists. Based on the physicians' letters, they can classify the patient's rehospitalization in three categories: "drug-related", "not drug-related" or "questionably drug-related". If the panel of experts decides that the rehospitalization is "questionably drug-related", other three pharmacists will assess the case according to the three categories. The primary endpoint is assessed for each participant during the follow-up 30 days and 90 days after discharge from hospital.

Secondary

MeasureTime frame
The following secondary endpoints will be assessed: total number of rehospitalizations, duration of rehabilitation in days, number of days spent at home, increase in the degree of care, institutionalization, and mortality. With regard to secondary endpoints, participants will be contacted by telephone during the follow-up 30 days and 90 days after discharge.

Countries

Germany

Contacts

Public ContactAnnelie Friederike Goldbeck

Uniklinik Köln - Apotheke

annelie.goldbeck@uk-koeln.de004922147888478

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026